2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Conditions
Melanoma
3141
Skin Neoplasms
554
Lymphoma, T-Cell, Cutaneous
543
Carcinoma, Non-Small-Cell Lung
421
Neoplasms
388
Mycosis Fungoides
369
Breast Neoplasms
364
Carcinoma, Basal Cell
360
Keratosis, Actinic
335
Sezary Syndrome
331
Lymphoma, Non-Hodgkin
312
Carcinoma, Renal Cell
308
Neoplasm Metastasis
304
Lymphoma
300
Leukemia, Lymphocytic, Chronic, B-Cell
292
Lymphoma, Large B-Cell, Diffuse
287
Lymphoma, Follicular
286
Hodgkin Disease
275
Uveal Melanoma
274
Lymphoma, B-Cell, Marginal Zone
273
Lymphoma, Mantle-Cell
272
Precursor Cell Lymphoblastic Leukemia-Lymphoma
271
Burkitt Lymphoma
258
Lymphoma, Large-Cell, Immunoblastic
248
Lung Neoplasms
236
Colorectal Neoplasms
232
Ovarian Neoplasms
214
Lymphoma, Large-Cell, Anaplastic
206
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
203
Multiple Myeloma
199
Interventions
Mohs Surgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Adnexal and Skin Appendage
×
Dermatologic
×
Clear all
NCT02310503
2020-05-05
REGESMOHS
Fundación Academia Española de Dermatología
Completed
6,000 enrolled